Proposed Collection; Comment Request; National Institutes of Health Loan Repayment Programs, 7570-7571 [2011-2995]
Download as PDF
<![CDATA[
7570
Federal Register / Vol. 76, No. 28 / Thursday, February 10, 2011 / Notices
The Presidential Commission
for the Study of Bioethical Issues will
conduct its fourth meeting. At this
meeting, the Commission will discuss
genetics, neuroscience, and
neuroimaging for testing, research,
diagnosis, risk identification, and health
promotion. The Commission will also
begin a review of human subjects
protection.
SUMMARY:
The meeting will take place
Monday, February 28, 2011, from 9 a.m.
to approximately 4:30 p.m., and
Tuesday, March 1, 2011, from 9 a.m. to
approximately 12:30 p.m.
ADDRESSES: The St. Regis Hotel,
Washington, DC, 923 16th and K Streets,
NW., Washington, DC 20006. Phone
202–638–2626.
FOR FURTHER INFORMATION CONTACT:
Hillary Wicai Viers, Communications
Director, The Presidential Commission
for the Study of Bioethical Issues, 1425
New York Avenue, NW., Suite C–100,
Washington, DC 20005. Telephone:
202–233–3963. E-mail:
Hillary.Viers@bioethics.gov. Additional
information may be obtained at https://
www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to the Federal Advisory Committee Act
of 1972, Public Law 92–463, 5 U.S.C.
app. 2, notice is hereby given of the
fourth meeting of the Presidential
Commission for the Study of Bioethical
Issues (PCSBI). The meeting will be held
from 9 a.m. to approximately 4:30 p.m.
on Monday, February 28, 2011, and
from 9 a.m. to approximately 12:30 p.m.
on Tuesday, March 1, 2011, at the St.
Regis Hotel, Washington, DC. The
meeting will be open to the public with
attendance limited to space available.
The meeting will also be webcast at
https://www.bioethics.gov.
Under authority of Executive Order
13521, dated November 24, 2009, the
President established PCSBI to serve as
a public forum and advise him on
bioethical issues generated by novel and
emerging research in biomedicine and
related areas of science and technology.
The Commission is charged to identify
and promote policies and practices that
assure ethically responsible conduct of
scientific research, healthcare delivery,
and technological innovation. In
undertaking these duties, the
Commission will examine specific
bioethical, legal, and social issues
related to potential scientific and
technological advances; examine
diverse perspectives and possibilities
for useful international collaboration on
these issues; and recommend legal,
regulatory, or policy actions as
appropriate.
jdjones on DSK8KYBLC1PROD with NOTICES
DATES:
VerDate Mar<15>2010
15:10 Feb 09, 2011
Jkt 223001
The main agenda items for this fourth
meeting involve genetics, neuroscience,
and neuroimaging; and a review of
human subjects protection. Specifically,
the Commission is interested in
exploring social and ethical issues
involving genetics, neuroscience, and
neuroimaging used for research,
diagnosis, risk identification, and
prevention. The Commission will also
begin its review of human subjects
protection as requested by President
Obama on November 24, 2010.
The draft meeting agenda and other
information about PCSBI, including
information about access to the webcast,
will be available at https://
www.bioethics.gov.
The Commission welcomes input
from anyone wishing to provide public
comment on any issue before it. The
Commission’s goal, time permitting, is
to invite brief public comment during
each meeting session. Individuals who
would like to provide public comment
at the meeting should notify Esther Yoo
by telephone at 202–233–3960, or e-mail
at Esther.Yoo@bioethics.gov. To
accommodate as many speakers as
possible the time for public comments
may be limited. If the number of
individuals wishing to speak is greater
than can reasonably be accommodated
during the scheduled meeting, the
Commission may randomly select
speakers from among those who register
to speak.
Anyone planning to attend the
meeting who needs special assistance,
such as sign language interpretation or
other reasonable accommodations,
should also notify Esther Yoo (contact
information above) in advance of the
meeting. The Commission will make
every effort to accommodate persons
who need special assistance.
Written comments will also be
accepted and are especially welcome.
Please address written comments by email to info@bioethics.gov, or by mail to
the following address: Public
Commentary, The Presidential
Commission for the Study of Bioethical
Issues, 1425 New York Ave., NW., Suite
C–100, Washington, DC 20005.
Comments will be publicly available,
including any personally identifiable or
confidential business information that
they contain. Trade secrets should not
be submitted.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment
Request; National Institutes of Health
Loan Repayment Programs
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
Division of Loan Repayment, National
Institutes of Health (NIH), will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Proposed Collection: Title: National
Institutes of Health Loan Repayment
Programs. Type of Information
Collection Request: Extension of a
currently approved collection (OMB No.
0925–0361, expiration date 06/30/11).
Form Numbers: NIH 2674–1, NIH 2674–
2, NIH 2674–3, NIH 2674–4, NIH 2674–
5, NIH 2674–6, NIH 2674–7, NIH 2674–
8, NIH 2674–9, NIH 2674–10, NIH
2674–11, NIH 2674–12, NIH 2674–13,
NIH 2674–14, NIH 2674–15, NIH 2674–
16, NIH 2674–17, NIH 2674–18, and
NIH 2674–19. Need and Use of
Information Collection: The NIH makes
available financial assistance, in the
form of educational loan repayment, to
M.D., PhD, Pharm.D., D.D.S., D.M.D.,
D.P.M., D.C., and N.D. degree holders,
or the equivalent, who perform
biomedical or behavioral research in
NIH intramural laboratories or as
extramural grantees or scientists funded
by domestic nonprofit organizations for
a minimum of 2 years (3 years for the
General Research Loan Repayment
Program (LRP)) in research areas
supporting the mission and priorities of
the NIH.
The AIDS Research LRP (AIDS–LRP)
is authorized by section 487A of the
Public Health Service Act (PHS Act) (42
U.S.C. 288–1), and the Clinical Research
LRP for Individuals from Disadvantaged
Backgrounds (CR–LRP) is authorized by
section 487E (42 U.S.C. 288–5). The
General Research LRP (GR–LRP) is
authorized by section 487C of the PHS
Act (42 U.S.C. 288–3), and the Clinical
Research LRP (LRP–CR) is authorized by
section 487F (42 U.S.C. 288–5a). The
Pediatric Research LRP (PR–LRP) is
authorized by section 487F of the PHS
Dated: February 2, 2011.
Act (42 U.S.C. 288–6), and the
Valerie H. Bonham,
Extramural Clinical Research LRP for
Executive Director, The Presidential
Individuals from Disadvantaged
Commission for the Study of Bioethical Issues. Backgrounds (ECR–LRP) is authorized
[FR Doc. 2011–3023 Filed 2–9–11; 8:45 am]
by an amendment to section 487E (42
U.S.C. 288–5). The Contraception and
BILLING CODE 4154–06–P
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
SUMMARY:
E:\FR\FM\10FEN1.SGM
10FEN1
7571
Federal Register / Vol. 76, No. 28 / Thursday, February 10, 2011 / Notices
Infertility Research LRP (CIR–LRP) is
authorized by section 487B of the PHS
Act (42 U.S.C. 288–2), and the Health
Disparities Research LRP (HD–LRP) is
authorized by section 485G (42 U.S.C.
287c–33).
The Loan Repayment Programs can
repay up to $35,000 per year toward a
participant’s extant eligible educational
loans, directly to financial institutions.
The information proposed for collection
will be used by the Division of Loan
Repayment to determine an applicant’s
eligibility for participation in the
program. Frequency of Response: Initial
application and one- or two-year
Estimated
number of
responses per
respondent
Number of
respondents
Type of respondents
renewal application. Affected Public:
Individuals or households, nonprofits,
and businesses or other for-profit. Type
of Respondents: Physicians, other
scientific or medical personnel, and
institutional representatives. The annual
reporting burden is as follows:
Average
burden hours
per response
Annual burden
hours requested
50
50
140
10
1
1
1
1
10.11
1
.5
.25
505.50
50.00
70.00
2.50
Subtotal .............................................................................
250
............................
............................
628.00
Extramural LRPs:
Initial Applicants ........................................................................
Advisors/Supervisors ................................................................
Recommenders ........................................................................
Financial Institutions .................................................................
2,050
1,840
6,150
100
1
1
1
1
10.75
1
.5
.25
22,037.50
1,840.00
3,075.00
25.00
Subtotal .............................................................................
10,140
............................
............................
26,977.50
Intramural LRPs:
Renewal Applicants ..................................................................
Advisors/Supervisors ................................................................
50
50
1
1
7.42
2.2
371.00
110.00
Subtotal .............................................................................
100
............................
............................
481.00
Extramural LRPS:
Renewal Applicants ..................................................................
Advisors/Supervisors ................................................................
Recommenders ........................................................................
1,200
900
3,500
1
1
1
8.58
1.7
.5
10,296.00
1,530.00
1,750.00
Subtotal .............................................................................
5,600
............................
............................
13,576.00
Total ...........................................................................
jdjones on DSK8KYBLC1PROD with NOTICES
Intramural LRPs:
Initial Applicants ........................................................................
Advisors/Supervisors ................................................................
Recommenders ........................................................................
Financial Institutions .................................................................
16,090
............................
............................
41,662.50
The annualized cost to respondents is
estimated at $1,701,641.69. The
annualized cost to the Federal
Government for administering the Loan
Repayment Programs is expected to be
$1,448,100. This cost includes
administrative support by the Division
of Loan Repayment and $800,000 for the
continuing development and
maintenance of the LRP Management
Information System/Online Application
System (MIS/OAS).
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
VerDate Mar<15>2010
15:10 Feb 09, 2011
Jkt 223001
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Milton Hernandez,
PhD, Director, Division of Loan
Repayment, National Institutes of
Health, 6011 Executive Blvd., Room 206
(MSC 7650), Bethesda, Maryland
20892–7650. Dr. Hernandez may be
contacted via e-mail at mh35c.@nih.gov
or by calling 301–496–0180.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Dated: February 4, 2011.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2011–2995 Filed 2–9–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 USC,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
E:\FR\FM\10FEN1.SGM
10FEN1
]]>Agencies
[Federal Register Volume 76, Number 28 (Thursday, February 10, 2011)]
[Notices]
[Pages 7570-7571]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-2995]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment Request; National Institutes of
Health Loan Repayment Programs
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the Division of Loan Repayment,
National Institutes of Health (NIH), will publish periodic summaries of
proposed projects to be submitted to the Office of Management and
Budget (OMB) for review and approval.
Proposed Collection: Title: National Institutes of Health Loan
Repayment Programs. Type of Information Collection Request: Extension
of a currently approved collection (OMB No. 0925-0361, expiration date
06/30/11). Form Numbers: NIH 2674-1, NIH 2674-2, NIH 2674-3, NIH 2674-
4, NIH 2674-5, NIH 2674-6, NIH 2674-7, NIH 2674-8, NIH 2674-9, NIH
2674-10, NIH 2674-11, NIH 2674-12, NIH 2674-13, NIH 2674-14, NIH 2674-
15, NIH 2674-16, NIH 2674-17, NIH 2674-18, and NIH 2674-19. Need and
Use of Information Collection: The NIH makes available financial
assistance, in the form of educational loan repayment, to M.D., PhD,
Pharm.D., D.D.S., D.M.D., D.P.M., D.C., and N.D. degree holders, or the
equivalent, who perform biomedical or behavioral research in NIH
intramural laboratories or as extramural grantees or scientists funded
by domestic nonprofit organizations for a minimum of 2 years (3 years
for the General Research Loan Repayment Program (LRP)) in research
areas supporting the mission and priorities of the NIH.
The AIDS Research LRP (AIDS-LRP) is authorized by section 487A of
the Public Health Service Act (PHS Act) (42 U.S.C. 288-1), and the
Clinical Research LRP for Individuals from Disadvantaged Backgrounds
(CR-LRP) is authorized by section 487E (42 U.S.C. 288-5). The General
Research LRP (GR-LRP) is authorized by section 487C of the PHS Act (42
U.S.C. 288-3), and the Clinical Research LRP (LRP-CR) is authorized by
section 487F (42 U.S.C. 288-5a). The Pediatric Research LRP (PR-LRP) is
authorized by section 487F of the PHS Act (42 U.S.C. 288-6), and the
Extramural Clinical Research LRP for Individuals from Disadvantaged
Backgrounds (ECR-LRP) is authorized by an amendment to section 487E (42
U.S.C. 288-5). The Contraception and
[[Page 7571]]
Infertility Research LRP (CIR-LRP) is authorized by section 487B of the
PHS Act (42 U.S.C. 288-2), and the Health Disparities Research LRP (HD-
LRP) is authorized by section 485G (42 U.S.C. 287c-33).
The Loan Repayment Programs can repay up to $35,000 per year toward
a participant's extant eligible educational loans, directly to
financial institutions. The information proposed for collection will be
used by the Division of Loan Repayment to determine an applicant's
eligibility for participation in the program. Frequency of Response:
Initial application and one- or two-year renewal application. Affected
Public: Individuals or households, nonprofits, and businesses or other
for-profit. Type of Respondents: Physicians, other scientific or
medical personnel, and institutional representatives. The annual
reporting burden is as follows:
----------------------------------------------------------------------------------------------------------------
Estimated number Average burden
Type of respondents Number of of responses per hours per Annual burden
respondents respondent response hours requested
----------------------------------------------------------------------------------------------------------------
Intramural LRPs:
Initial Applicants.................. 50 1 10.11 505.50
Advisors/Supervisors................ 50 1 1 50.00
Recommenders........................ 140 1 .5 70.00
Financial Institutions.............. 10 1 .25 2.50
-----------------------------------------------------------------------
Subtotal........................ 250 ................ ................ 628.00
-----------------------------------------------------------------------
Extramural LRPs:
Initial Applicants.................. 2,050 1 10.75 22,037.50
Advisors/Supervisors................ 1,840 1 1 1,840.00
Recommenders........................ 6,150 1 .5 3,075.00
Financial Institutions.............. 100 1 .25 25.00
-----------------------------------------------------------------------
Subtotal........................ 10,140 ................ ................ 26,977.50
----------------------------------------------------------------------------------------------------------------
Intramural LRPs:
Renewal Applicants.................. 50 1 7.42 371.00
Advisors/Supervisors................ 50 1 2.2 110.00
-----------------------------------------------------------------------
Subtotal........................ 100 ................ ................ 481.00
-----------------------------------------------------------------------
Extramural LRPS:
Renewal Applicants.................. 1,200 1 8.58 10,296.00
Advisors/Supervisors................ 900 1 1.7 1,530.00
Recommenders........................ 3,500 1 .5 1,750.00
-----------------------------------------------------------------------
Subtotal........................ 5,600 ................ ................ 13,576.00
-----------------------------------------------------------------------
Total....................... 16,090 ................ ................ 41,662.50
----------------------------------------------------------------------------------------------------------------
The annualized cost to respondents is estimated at $1,701,641.69.
The annualized cost to the Federal Government for administering the
Loan Repayment Programs is expected to be $1,448,100. This cost
includes administrative support by the Division of Loan Repayment and
$800,000 for the continuing development and maintenance of the LRP
Management Information System/Online Application System (MIS/OAS).
Request for Comments: Written comments and/or suggestions from the
public and affected agencies should address one or more of the
following points: (1) Whether the proposed collection of information is
necessary for the proper performance of the function of the agency,
including whether the information will have practical utility; (2) the
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) ways to minimize
the burden of the collection of information on those who are to
respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Milton Hernandez, PhD, Director, Division of Loan
Repayment, National Institutes of Health, 6011 Executive Blvd., Room
206 (MSC 7650), Bethesda, Maryland 20892-7650. Dr. Hernandez may be
contacted via e-mail at mh35c.@nih.gov or by calling 301-496-0180.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Dated: February 4, 2011.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2011-2995 Filed 2-9-11; 8:45 am]
BILLING CODE 4140-01-P
